SeaBridge Investment Advisors’s Gilead Sciences GILD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-18,300
| Closed | -$1.33M | – | 145 |
|
|
2021
Q4 | $1.33M | Sell |
18,300
-1,605
| -8% | -$111K | 0.43% | 80 |
|
|
2021
Q3 | $1.39M | Buy |
19,905
+195
| +1% | +$13.7K | 0.46% | 78 |
|
|
2021
Q2 | $1.36M | Sell |
19,710
-709
| -3% | -$47.3K | 0.44% | 82 |
|
|
2021
Q1 | $1.32M | Buy |
20,419
+10,330
| +102% | +$666K | 0.44% | 81 |
|
|
2020
Q4 | $588K | Sell |
10,089
-18,901
| -65% | -$1.14M | 0.21% | 105 |
|
|
2020
Q3 | $1.83M | Sell |
28,990
-395
| -1% | -$27.4K | 0.68% | 54 |
|
|
2020
Q2 | $2.26M | Buy |
29,385
+792
| +3% | +$60.7K | 0.88% | 45 |
|
|
2020
Q1 | $2.14M | Sell |
28,593
-90
| -0.3% | -$6.22K | 0.98% | 38 |
|
|
2019
Q4 | $1.86M | Buy |
28,683
+4,743
| +20% | +$309K | 0.65% | 62 |
|
|
2019
Q3 | $1.52M | Sell |
23,940
-450
| -2% | -$29.4K | 0.52% | 66 |
|
|
2019
Q2 | $1.65M | Sell |
24,390
-980
| -4% | -$64.5K | 0.55% | 70 |
|
|
2019
Q1 | $1.65M | Sell |
25,370
-53
| -0.2% | -$3.52K | 0.55% | 72 |
|
|
2018
Q4 | $1.59M | Buy |
25,423
+485
| +2% | +$33.9K | 0.58% | 70 |
|
|
2018
Q3 | $1.93M | Sell |
24,938
-1,430
| -5% | -$108K | 0.49% | 70 |
|
|
2018
Q2 | $1.87M | Sell |
26,368
-3,905
| -13% | -$276K | 0.46% | 72 |
|
|
2018
Q1 | $2.28M | Buy |
30,273
+210
| +0.7% | +$16.7K | 0.51% | 65 |
|
|
2017
Q4 | $2.15M | Buy |
30,063
+10,793
| +56% | +$820K | 0.47% | 70 |
|
|
2017
Q3 | $1.56M | Buy |
19,270
+18,670
| +3,112% | +$1.43M | 0.36% | 87 |
|
|
2017
Q2 | $42K | Sell |
600
-12,802
| -96% | -$852K | 0.01% | 181 |
|
|
2017
Q1 | $910K | Sell |
13,402
-1,917
| -13% | -$135K | 0.22% | 104 |
|
|
2016
Q4 | $1.1M | Sell |
15,319
-782
| -5% | -$58.1K | 0.26% | 100 |
|
|
2016
Q3 | $1.27M | Sell |
16,101
-130
| -0.8% | -$10.6K | 0.32% | 95 |
|
|
2016
Q2 | $1.35M | Sell |
16,231
-1,518
| -9% | -$135K | 0.34% | 91 |
|
|
2016
Q1 | $1.63M | Sell |
17,749
-458
| -3% | -$41.3K | 0.4% | 77 |
|
|
2015
Q4 | $1.84M | Sell |
18,207
-38
| -0.2% | -$3.95K | 0.41% | 80 |
|
|
2015
Q3 | $1.79M | Buy |
18,245
+380
| +2% | +$42.2K | 0.42% | 78 |
|
|
2015
Q2 | $2.09M | Buy |
17,865
+243
| +1% | +$26.6K | 0.43% | 75 |
|
|
2015
Q1 | $1.73M | Buy |
17,622
+462
| +3% | +$46.9K | 0.35% | 81 |
|
|
2014
Q4 | $1.62M | Buy |
17,160
+2,980
| +21% | +$308K | 0.33% | 86 |
|
|
2014
Q3 | $1.51M | Sell |
14,180
-3,480
| -20% | -$341K | 0.35% | 84 |
|
|
2014
Q2 | $1.46M | Buy |
+17,660
| New | +$1.37M | 0.3% | 88 |
|
|
2014
Q1 | – | Sell |
-4,480
| Closed | -$336K | – | 208 |
|
|
2013
Q4 | $336K | Hold |
4,480
| – | – | 0.07% | 123 |
|
|
2013
Q3 | $282K | Hold |
4,480
| – | – | 0.07% | 129 |
|
|
2013
Q2 | $230K | Buy |
+4,480
| New | +$234K | 0.06% | 129 |
|
Other funds holding GILD
SeaBridge Investment Advisors's GILD Position: Q1 2022 in Review
SeaBridge Investment Advisors sold out of Gilead Sciences (GILD) in Q1 2022, closing a stake of 18,300 shares — an estimated $1.33M sold.
SeaBridge Investment Advisors first reported a position in GILD in Q2 2013 and held it in 34 quarters. The position peaked at $2.28M in Q1 2018. 1,601 funds tracked by Wall St. Rank hold GILD as of Q1 2022.
- SeaBridge Investment Advisors reported no remaining Gilead Sciences position as of Q1 2022 after selling out during the quarter.
- SeaBridge Investment Advisors sold 18,300 Gilead Sciences shares in Q1 2022, an estimated $1.33M.
- SeaBridge Investment Advisors first reported a position in Gilead Sciences in Q2 2013 and held it in 34 quarters.
- SeaBridge Investment Advisors's Gilead Sciences position peaked at $2.28M in Q1 2018.
- 1,601 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2022.
Based on SeaBridge Investment Advisors's 13F filing for Q1 2022, filed 9 May 2022.